Cite
HARVARD Citation
Rosenstock, J. et al. (2018). Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET). Diabetes, obesity & metabolism. 20 (3), pp. 520-529. [Online].